Heart:战争给人留下了多大的创伤?显著影响日后心血管病风险!

2021-11-29 MedSci原创 MedSci原创

CRTI与MetS和动脉僵化患病率的增加有关,这也受到年龄、受伤严重程度、体力活动和SEC的影响。

与战斗有关的创伤(CRTI)的幸存者的长期健康结果尚不清楚。据报道,严重的CRTI可能与心血管疾病(CVD)和主要不良心血管事件(MACE)的风险增加有关。然而,最近的一项系统回顾和荟萃分析表明,这一证据的强度充其量是中度的。

因此,有必要进行一项当代前瞻性队列研究,检查CRTI及其严重程度与早期心血管风险标志物之间的关系。针对该问题,来自英国拉夫堡国防医疗康复中心军事康复学术中心的专家开展了相关研究,旨在调查CRTI与代谢综合征(MetS)和动脉僵化之间的关系。结果发表在Heart杂志上。

这是一项前瞻性的观察性队列研究,包括579名患有CRTI的英国成年男性战斗退伍军人(英国-阿富汗战争2003-2014),他们与565名未受伤的男性按年龄、兵种、军衔、军团、部署时期和战区角色进行了匹配。措施包括量化损伤严重程度(新损伤严重程度评分(NISS))、内脏脂肪面积(双能X射线吸收仪)、动脉僵化(心率调整的中心增强指数(cAIx)和脉搏波速度(PWV))、空腹静脉血糖、血脂和高敏C反应蛋白(hs-CRP)。

结果显示,总的来说,参与者的年龄为(34.1±5.4)岁,平均(±SD)从受伤/部署的时间为(8.3±2.1)年。与未受伤组相比,CRTI组MetS的患病率高46%(18.0% vs 11.8%;RR=1.46,95% CI 1.10-1.94,p<0.0001)、平均cAIx更严重(17.61%±8.79% vs 15.23%±8.19%,p<0.0001)。

按受伤/未受伤和受伤严重程度分类,代谢综合征和(B)cAIx与战斗相关创伤的回归分析结果.

同时,CRTI组的腹部腰围、内脏脂肪面积、甘油三酯、估计的胰岛素抵抗和hs-CRP水平更高,而体力活动和高密度脂蛋白胆固醇(好胆固醇)更低。在血糖、血压或脉搏波速度方面没有明显的组间差异。其中,CRTI、损伤严重程度、年龄、社会经济地位(SEC)和体力活动都与MetS和cAIx独立相关。

综上,CRTI与MetS和动脉僵化患病率的增加有关,这也受到年龄、受伤严重程度、体力活动和SEC的影响。

 

参考文献:

Association between combat-related traumatic injury and cardiovascular risk. http://dx.doi.org/10.1136/heartjnl-2021-320296

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1644924, encodeId=6c5516449240d, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Wed May 04 22:50:00 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335375, encodeId=9d1b13353e5a7, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Wed Dec 01 05:50:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357835, encodeId=e07a135e83583, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Dec 01 05:50:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563552, encodeId=5af615635529f, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Dec 01 05:50:00 CST 2021, time=2021-12-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1644924, encodeId=6c5516449240d, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Wed May 04 22:50:00 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335375, encodeId=9d1b13353e5a7, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Wed Dec 01 05:50:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357835, encodeId=e07a135e83583, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Dec 01 05:50:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563552, encodeId=5af615635529f, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Dec 01 05:50:00 CST 2021, time=2021-12-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1644924, encodeId=6c5516449240d, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Wed May 04 22:50:00 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335375, encodeId=9d1b13353e5a7, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Wed Dec 01 05:50:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357835, encodeId=e07a135e83583, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Dec 01 05:50:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563552, encodeId=5af615635529f, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Dec 01 05:50:00 CST 2021, time=2021-12-01, status=1, ipAttribution=)]
    2021-12-01 zhaojie88
  4. [GetPortalCommentsPageByObjectIdResponse(id=1644924, encodeId=6c5516449240d, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Wed May 04 22:50:00 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335375, encodeId=9d1b13353e5a7, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Wed Dec 01 05:50:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357835, encodeId=e07a135e83583, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Dec 01 05:50:00 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563552, encodeId=5af615635529f, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Dec 01 05:50:00 CST 2021, time=2021-12-01, status=1, ipAttribution=)]
    2021-12-01 slcumt

相关资讯

实锤了!肚子越大,脑子越小!除了减肥,还有别的办法防变傻吗?

近期,来自美国马歇尔大学的学者在iScience杂志上发表了一项氧化剂放大循环的研究,结果揭示了脂肪细胞在认知能力下降和神经变性中的作用。

OMCL:代谢综合征妇女血清胎球蛋白-B水平升高并与氧化应激增加相关

以往对血清胎球蛋白-B(胎球蛋白样蛋白IRL685)与T2 DM的关系已有研究,但血清胎球蛋白-B变化的原因及其在代谢性疾病中的调节因子尚不清楚。

人“胖”就要多读书!多赚钱也行!代谢综合征缓解与这些社会经济因素相关

INT J BEHAV NUTR PHY:理解成人代谢综合征缓解的社会经济差异:健康行为的中介作用是什么?

Viruses:代谢综合征在COVID-19患者中的预后作用

代谢综合征 (MetS) 在感染 SARS-CoV-2 的患者中的患病率和预后影响尚不清楚。我们对 COVID-19 代谢综合征患者的患病率和死亡风险进行了系统回顾和荟萃分析。

风险因素男女有别!代谢综合征如何升高两性肝癌风险?

BMC Cancer:代谢综合征及其组成特征与肝癌风险存在性别特异性关联:一项前瞻性队列研究

拓展阅读

JCEM:胱抑素C是代谢综合征患者长期全因和心血管死亡率的预测因子

CysC水平升高的MetS患者有更高的全因、心血管疾病和癌症死亡风险。CysC可以预测MetS患者全因死亡率和CVD死亡率。

中国成人年龄、性别、种族特异性代谢综合征评分(MetS score)

中国成人年龄、性别、种族特异性代谢综合征评分(MetS score)

BMC MED:代谢综合征、血清尿酸与痴呆症风险之间的关系——一项前瞻性队列研究

本研究提供了强有力的证据,支持 MetS 及其组成部分与痴呆症风险之间的关联。

BMC Public Health:农村慢性丙型肝炎成人中脂肪肝的高患病率及其与代谢综合征的相关性

最近据世界卫生组织估计,2019年全球有5800万人感染了丙型肝炎病毒(HCV),约有29万人死于丙型肝炎,主要与肝硬化和肝细胞癌(HCC或肝癌)有关。

Nat Commun:中国成人年龄、性别、种族特异性代谢综合征评分的建立与验证

代谢综合征(MetS)主要表现为一系列代谢功能障碍,包括糖耐量受损、血脂异常、高血压和中枢性肥胖。这些代谢功能障碍,也称为代谢障碍成分,被认为是心血管疾病(CVD)的相关危险因素。

BMC Geriatr:1999 - 2018年美国成年人代谢综合征患病率、干预和控制的趋势和影响因素

我们旨在描述1999-2018年美国成年人代谢综合征(MetS)的患病率、干预和控制趋势。此外,还进一步探讨了MetS的影响因素及其控制方法。